The clinical promise of 18F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease

By sjmartinez • January 19, 2025

Packard RRS. The clinical promise of ¹⁸F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease. Nat Cardiovasc Res. 2025 Jan;4(1):1-4. doi: 10.1038/s44161-024-00587-w. PMID: 39825085.

Tags: Cardiology/Epi, Publications

Trends in Cardiovascular Mortality in Patients With Chronic Kidney Disease From 1999 to 2020: A Retrospective Study in the United States

Ahmad E, Ahmad S, Naeem A, Ahmed S, Shehzad M, Akram U, Ashraf H, Rehman OU, Ullah I, Ahmed R, Alraies C, Fonarow GC. Trends[...]

Right Coronary Artery Occlusion due to Adventitial Hematoma During Cavotricuspid Isthmus Ablation

Asada H, Takami M, Mori S, Izawa Y, Kawamori H, Fukuzawa K. Right Coronary Artery Occlusion due to Adventitial Hematoma During Cavotricuspid Isthmus Ablation. JACC[...]

Diabetes and longitudinal changes in deep learning-derived measures of vertebral bone mineral density using conventional CT: the Multi-Ethnic Study of Atherosclerosis

Ghotbi E, Hadidchi R, Hathaway QA, Bancks MP, Bluemke DA, Barr RG, Smith BM, Post WS, Budoff M, Lima JAC, Demehri S. Diabetes and longitudinal[...]